Long-term effects of somatostatin analogues in rat GH-secreting pituitary tumor cell lines

PURPOSE: First-generation somatostatin analogs, octreotide (OCT) and lanreotide, are the cornerstone for the medical treatment of growth hormone (GH)-secreting pituitary tumors. A new multireceptor analog, such as pasireotide (PAS), showed better activity than OCT in long-term treatment of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Dicitore, A., Saronni, D., Gaudenzi, G., Carra, S., Cantone, M. C., Borghi, M. O., Persani, L., Vitale, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741688/
https://www.ncbi.nlm.nih.gov/pubmed/34128215
http://dx.doi.org/10.1007/s40618-021-01609-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741688/
https://www.ncbi.nlm.nih.gov/pubmed/34128215
http://dx.doi.org/10.1007/s40618-021-01609-1

Ejemplares similares